Biosintex
Biosintex Laboratorios is an Argentine pharmaceutical laboratory that develops and manufactures prescription, OTC, mass-consumption, and dermocosmetic products, distributing through 20+ exclusive sales agents to 4,000+ pharmacies nationwide.
- Company typePrivate
- Founded1998
- HeadquartersBuenos Aires, Argentina
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Biosintex firmographics
Firmographics- Name
- Biosintex
- Legal name
- Biosintex Laboratorios
- Website
- https://biosintex.com.ar
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Biosintex Laboratorios is an Argentine pharmaceutical laboratory that develops and manufactures prescription, OTC, mass-consumption, and dermocosmetic products, distributing through 20+ exclusive sales agents to 4,000+ pharmacies nationwide.
- Ownership category
- akta.pro rank
Biosintex industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
- akta.pro secondary industries
- Dermatology Specialty Pharmaceuticals (HLAIACAL), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
Keywords
Where Biosintex is headquartered
LocationHeadquarters
- HQ city
- Buenos Aires
- HQ country
- Argentina
- HQ region
- Latin America
Offices3 records
Markets served
Biosintex business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical and Cosmetic Product Sales: Biosintex manufactures and sells pharmaceutical medicinal products and pharmaceutical cosmetics across multiple therapeutic lines including prescription medicine, over-the-counter, dermocosmetics, and special treatments. Products are distributed directly to pharmacies and drugstores nationwide.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Biosintex product offering
Product offeringCore offering
Biosintex develops and manufactures pharmaceutical medicinal products (prescription and over-the-counter) and pharmaceutical cosmetics (dermocosmetics) at two production plants in Argentina spanning more than 3,000 m². The company operates across five therapeutic lines — prescription medicine, special treatments, dermocosmetics, mass consumption, and over-the-counter (venta libre) — producing a portfolio of over 100 products distributed to more than 4,000 pharmacies and drugstores nationwide through a network of over 20 exclusive Pharmaceutical Promotion Agents (APFs).
Product overview
Biosintex is an Argentine pharmaceutical laboratory with over 25 years of experience developing and manufacturing medicinal and pharmaceutical cosmetic products. The company operates across five therapeutic lines: prescription medicine (Ibulgia ibuprofen products, Vitergin vitamin D3, Lacrigestina eye drops, Pancreolipasa for cystic fibrosis), over-the-counter products (Ginezolex Intimo intimate care), mass consumption (Bucoangin antibiotic lozenges, Tavinex cough syrups, Vitacortil antifungal creams), and dermocosmetics. The dermocosmetics division includes two sub-brands: Vitamidermus (high vitamin content skincare for sensitive skin including moisturizers, regenerating creams, tonics, facial mists, and antioxidant serums with ingredients like Niacinamide, Vitamin E, CBD, and peptides), and Midermus (body care products including the DBT line with Urea and body sunscreens). The company manufactures at two facilities spanning over 3,000 m² and distributes to over 4,000 pharmacies nationwide through a network of pharmaceutical promotion agents.
Differentiator
Problem solved
Functional benefit
Brands
- Vitamidermus: Pharmaceutical cosmetics line with original in-house formulas, clinically and dermatologically tested for daily care of sensitive skin, featuring high content of vitamins and skin-barrier-strengthening active ingredients.
- Midermus
- Bucoangin
- Tavinex
- Vitacortil
- Ibulgia
- Lacrigestina
- Ginezolex
Products and services
- IBULGIA 4% Ibuprofen 4% oral suspension for pediatric use, available in orange and tutti frutti flavors, sugar-free and alcohol-free. For pharmacies and pediatric patients.
- IBULGIA COMPRIMIDOS Ibuprofen 600 mg coated tablets, analgesic and antipyretic medication for prescription use. Distributed to pharmacies nationwide.
- VITERGIN Colecalciferol (Vitamin D3) 2 ml oral solution for preventing vitamin D deficiency and supporting bone strengthening. Distributed to pharmacies.
- GINEZOLEX Clotrimazole 1% antifungal treatment. For pharmacy distribution.
- Lacrigestina Ophthalmic drops for treating dry eye syndrome. Distributed to pharmacies.
- Pancreolipasa Prescription active ingredient used in treating cystic fibrosis. Distributed to pharmacies.
- Bucoangin Antibiotic lozenges for sore throat relief. Mass-consumption pharmaceutical product distributed to pharmacies.
- Tavinex Complete line of cough syrups. Mass-consumption pharmaceutical product distributed to pharmacies.
- Vitacortil Antifungal creams. Mass-consumption pharmaceutical product distributed to pharmacies.
- Ginezolex Íntimo Intimate care gel with L-arginine, hypoallergenic and gynecologically tested for daily use. Over-the-counter product distributed to pharmacies.
- VITAMIDERMUS HIDRATANTE FACIAL Facial moisturizer with Niacinamide 5%, Acquabio 3%, Vitamin A, and Vitamin E for daily sensitive skin care. Dermocosmetic distributed to pharmacies.
- VITAMIDERMUS REGENERADORA FACIAL Regenerating facial cream with Multi-Peptides, Niacinamide 5%, Vitamin A, and Vitamin E. Dermocosmetic for sensitive skin, distributed to pharmacies.
- VITAMIDERMUS TÓNICO FACIAL Hydrating and decongestant facial tonic with Niacinamide 3%, Miracne, and Urea. Completes the cleansing routine, balances the microbiome and reinforces skin barrier function.
- VITAMIDERMUS BRUMA FACIAL Facial mist with Niacinamide 3%, Panthenol, CICA, Calendula, and Urea for daytime rehydration and revitalization of the skin.
- VITAMIDERMUS E SERUM ANTIOXIDANTE Antioxidant serum with Vitamin E, Niacinamide 4%, Centella Asiatica, and Pro-Vitamin B5 for sensitive skin. Dermocosmetic distributed to pharmacies.
- Midermus DBT Body care product with Urea 10%, Shea Butter, Niacinamide, Vitamins A & E, and Pro-Vitamin B5 for improving dryness and cracked skin. Dermocosmetic distributed to pharmacies.
- VITAMIDERMUS FOTOPROTECTOR FACIAL 100% mineral facial photoprotector with photostable filters, Parsol TX, Titanium Dioxide, and Valvance Touch. Dermocosmetic sunscreen distributed to pharmacies.
- VITAMIDERMUS CBD SERUM REPARADOR FACIAL CBD-based repairing facial serum with Niacinamide, Centella Asiatica, and Provitamin B5. Dermocosmetic distributed to pharmacies.
- VITAMIDERMUS CBD BÁLSAMO RELIPIDIZANTE CBD relipidizing balm with Niacinamide, Centella Asiatica, and Provitamin B5. Dermocosmetic distributed to pharmacies.
- VITAMIDERMUS CREMA REPARADORA INTENSIVA MANOS Intensive repairing hand cream with BHNCARE, Vitamin A 250,000 IU, Niacinamide 4%, and Urea 2%. Dermocosmetic for hand care distributed to pharmacies.
Companies that use Biosintex
Customer profileNamed customers1 record
Segments6 records
Ideal customer profiles2 records
Biosintex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Biosintex partnerships and signals
Strategic signalScale indicators7 records
Recent moves5 records
Expansion highlights4 records
Biosintex competitors and assessment
Company assessmentDirect peers
- Laboratorios Gador: Argentine pharmaceutical company with a broad prescription and OTC portfolio plus dermatology and specialty lines, distributed nationally. Comparable therapeutic breadth and pharmacy-first GTM.
- Laboratorios Roemmers: Argentina's largest domestic pharmaceutical laboratory with a similar mix of prescription, OTC, and consumer health products distributed through pharmacies. Closest comparable in business model, scale aspiration, and therapeutic breadth within the Argentine market.
- Laboratorios Elea: Argentine pharmaceutical laboratory with branded generics, OTC, and consumer health products distributed through pharmacies. Directly comparable in size and channel mix.
- Laboratorios Richmond: Argentine pharmaceutical laboratory with branded prescription, OTC, and specialty products including dermatology lines. Comparable in scale, product portfolio diversity, and pharmacy distribution model.
- Laboratorios Raffo: Argentine pharmaceutical laboratory offering branded prescription, OTC, and consumer health products with national pharmacy distribution. Similar size tier and product breadth to Biosintex.
- Laboratorios Bagó: Large Argentine pharmaceutical laboratory with branded prescription, OTC, and consumer health products sold nationally through pharmacy channels. Highly comparable in product mix (analgesics, dermocosmetics, specialty treatments) and distribution model.
Regional players
- Genomma Lab Internacional: Mexican-headquartered Latin American pharmaceutical and personal care company with strong OTC and dermocosmetic portfolio (e.g., Tafirol, Goicoechea). Comparable in OTC/dermocosmetics positioning and pharmacy channel focus across LatAm.
- Eurofarma Laboratórios: Brazilian multinational pharmaceutical company with branded prescription, OTC, and generics across Latin America. Comparable in therapeutic breadth and pharmacy-led distribution model, with a track record of regional cross-border expansion relevant to Biosintex's next stage.
Broad incumbents
- Galderma: Global dermatology-focused pharmaceutical company (Cetaphil, Differin, etc.) with strong pharmacy and dermatologist channel presence. Directly competes with Vitamidermus/Midermus in sensitive-skin and dermatology categories, and represents the global standard Biosintex's dermocosmetics line is benchmarked against.
- Pierre Fabre Dermatologie: French pharmaceutical-dcosmetic group with dermatology brands (A-Derma, Avène, Ducray) sold through pharmacies globally. Comparable in "pharmaceutical cosmetics" positioning, dermatological active ingredients, and pharmacy channel distribution strategy.
Market position
Strengths5 records
Weaknesses2 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Biosintex social profiles
Digital presenceBiosintex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biosintex leadership team
Management profileNumber of profiles
Biosintex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biosintex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biosintex
What does Biosintex do?
Biosintex develops and manufactures pharmaceutical medicinal products (prescription and over-the-counter) and pharmaceutical cosmetics (dermocosmetics) at two production plants in Argentina spanning more than 3,000 m². The company operates across five therapeutic lines — prescription medicine, special treatments, dermocosmetics, mass consumption, and over-the-counter (venta libre) — producing a portfolio of over 100 products distributed to more than 4,000 pharmacies and drugstores nationwide through a network of over 20 exclusive Pharmaceutical Promotion Agents (APFs).
Is Biosintex a public or private company?
Biosintex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Biosintex founded?
Biosintex was founded in 1998. It employs 101 to 250 people.
Where is Biosintex based?
Biosintex is headquartered in Buenos Aires, Argentina, in the Latin America region.
How does Biosintex make money?
One revenue line is on record: pharmaceutical and Cosmetic Product Sales.
Who are Biosintex's main competitors?
Direct peers on record are Laboratorios Gador, Laboratorios Roemmers, Laboratorios Elea, Laboratorios Richmond, Laboratorios Raffo and Laboratorios Bagó. Regional players are Genomma Lab Internacional and Eurofarma Laboratórios. Broad incumbents are Galderma and Pierre Fabre Dermatologie.
Does Biosintex have an API?
No public API is recorded for Biosintex.
What industry is Biosintex in?
Biosintex's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of HLAIACAL, Dermatology Specialty Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.